Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia (PH94B-SAD)

This study has been completed.
Information provided by:
Pherin Pharmaceuticals, Inc. Identifier:
First received: September 30, 2010
Last updated: May 9, 2011
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):